Hims & Hers Health Inc [NYSE: HIMS] price plunged by -5.23 percent to reach at -$1.39.
The one-year HIMS stock forecast points to a potential upside of 9.66. The average equity rating for HIMS stock is currently 2.20, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Hims & Hers Health Inc [HIMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $27.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on December 17, 2024. The new note on the price target was released on November 14, 2024, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise to $24, while Needham analysts kept a Buy rating on HIMS stock.
The Average True Range (ATR) for Hims & Hers Health Inc is set at 2.53, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 4.13. The Price to Book ratio for the last quarter was 12.46, with the Price to Cash per share for the same quarter was set at 1.25. Price to Free Cash Flow for HIMS in the course of the last twelve months was 34.26 with Quick ratio for the last quarter at 1.82.
HIMS Stock Performance Analysis:
Hims & Hers Health Inc [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.93. With this latest performance, HIMS shares dropped by -17.04% in over the last four-week period, additionally plugging by 17.51% over the last 6 months – not to mention a rise of 178.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 42.09, with the RSI for the last a single of trading hit 34.97, and the three-weeks RSI is set at 46.26 for Hims & Hers Health Inc [HIMS]. The present Moving Average for the last 50 days of trading for this stock 26.15, while it was recorded at 27.19 for the last single week of trading, and 19.57 for the last 200 days.
Insight into Hims & Hers Health Inc Fundamentals:
Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.82 and a Current Ratio set at 2.14.
Hims & Hers Health Inc [HIMS] Institutonal Ownership Details
There are presently around $65.34%, or 73.77%% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.7166%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.8294%.
